-
Solesta approved by FDA as fecal incontinence treatment
SILVER SPRING, Md. — The Food and Drug Administration has approved an injectable gel for fecal incontinence, the agency said.
The FDA announced the approval of Oceana Therapeutics’ Solesta for patients who have involuntarily lost bowel control and for whom such therapies as diet change, fiber therapy and antimotility medications have failed.
Fecal incontinence affects more than 5.5 million Americans, according to the National Institutes of Health.
-
Lilly executive joins Chiquita's board
CINCINNATI — An Eli Lilly executive was elected to Chiquita's board of directors at the company's annual shareholders meeting.
Chiquita said that Jeffrey Simmons, who serves as Lilly SVP and president of the drug maker's animal health division, Elanco Animal Health, brings more than 20 years of management experience to his new role on the audit committee and the food innovation, safety and technology committee.